Regorafenib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Patients With Advanced Colorectal Cancer
Clinical trial NCT04771715 · UNKNOWN
Trial details
- NCT number
- NCT04771715
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-05-01
- Primary completion
- 2021-02-28
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.